Saint Francis Hospital and Medical Center

Saint Francis Hospital and Medical Center was paid $266.39M by Medicaid between Jan 2018 and Dec 2024, across 727 billing codes. Its largest line is 99285, emergency room visit (most serious) — 19% of everything it billed.

33Billing provider infoSAINT FRANCIS HOSPITAL AND MEDICAL CENTER
HARTFORD, CT 06105

33aNPI1871713495assigned 04/26/2007

33bProvider typeEmergency Medicine Physician

28Total paid$266.39M

24GClaims7,411,868

24DCodes billed727

24AFirst – last monthJan 2018 – Dec 2024

Compared with peers

Next to other Emergency Medicine Physician providers in Connecticut

Rank by total paid#1 of 92

Median peer was paid$10K

This provider vs. median26,666×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official HARRIS, JAMES controls 20+ related entities in our dataset. Read more

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	1,067,261	$38.18M
2019	1,185,699	$40.55M
2020	1,002,945	$35.66M
2021	1,178,028	$42.28M
2022	1,109,115	$41.46M
2023	1,013,265	$37.27M
2024incomplete	855,555	$30.99M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	19%	97,958	82,745	$50.26M
J2350	Injection, ocrelizumab, 1 mg	12%	1,930	1,645	$31.39M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	9.3%	80,575	70,824	$24.72M
G0463	Hospital outpatient clinic visit for assessment and management of a patient	6.8%	196,031	142,510	$18.23M
J2323	Injection, natalizumab, 1 mg	5.9%	4,105	3,489	$15.67M
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	5.7%	74,404	65,407	$15.32M
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	3.7%	70,021	56,701	$9.82M
99291	Critical care, evaluation and management of the critically ill patient, first 30-74 minutes	1.6%	6,029	5,357	$4.38M
J9271	Injection, pembrolizumab, 1 mg	1.6%	711	500	$4.16M
93458		1.4%	2,364	2,224	$3.67M
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	1.3%	15,990	9,873	$3.44M
74177	Computed tomography, abdomen and pelvis; with contrast material	1.1%	20,541	18,458	$3.00M

715 more codes

70450	Computed tomography, head or brain; without contrast material	1.1%	23,781	$2.99M
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	1.1%	42,011	$2.80M
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	<1%	22,600	$2.65M
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	5,256	$2.54M
96361	Intravenous infusion, hydration; each additional hour	<1%	47,697	$2.20M
27447		<1%	606	$2.18M
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	16,007	$2.17M
99282	Emergency department visit for the evaluation and management, low to moderate severity	<1%	15,945	$1.98M
71046	Radiologic examination, chest; 2 views	<1%	38,419	$1.96M
96375	Therapeutic injection; each additional sequential IV push	<1%	48,366	$1.85M
G0390	Trauma response team associated with hospital critical care service	<1%	2,624	$1.74M
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	2,566	$1.72M
59025	Fetal non-stress test	<1%	10,131	$1.49M
77067	Screening mammography, bilateral, including computer-aided detection	<1%	14,010	$1.48M
76811	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed	<1%	6,852	$1.38M
78815	Positron emission tomography (PET) for limited area imaging	<1%	1,990	$1.29M
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	5,247	$1.26M
77412		<1%	11,988	$1.18M
76801		<1%	11,154	$1.13M
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	2,588	$1.11M
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	44,368	$1.04M
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	<1%	44,334	$1.04M
74176	Computed tomography, abdomen and pelvis; without contrast material	<1%	8,099	$1.03M
77334		<1%	1,371	$892K
71045	Radiologic examination, chest; single view	<1%	21,621	$874K
45385	Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s)	<1%	1,580	$828K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	7,659	$826K
C8929	Transthoracic echocardiography with contrast, or without contrast followed by with contrast, real-time with image documentation (2d), includes m-mode recording, when performed, complete, with spectral doppler echocardiography, and with color flow doppler echocardiography	<1%	2,713	$761K
76830	Ultrasound, transvaginal	<1%	7,736	$749K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	7,852	$737K
70553	Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences	<1%	2,928	$730K
J0897	Injection, denosumab, 1 mg	<1%	928	$710K
76816	Ultrasound, pregnant uterus, real time with image documentation, follow-up	<1%	10,639	$704K
0202U	Oncology (prostate), multianalyte, gene expression profiling	<1%	2,433	$659K
94060		<1%	3,935	$628K
62323		<1%	1,597	$623K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	29,753	$619K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	5,850	$598K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	282,256	$568K
76805	Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation	<1%	5,484	$562K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	7,114	$559K
86900		<1%	34,378	$519K
70551	Magnetic resonance imaging, brain; without contrast material	<1%	4,015	$518K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	674	$483K
87635	Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe	<1%	13,578	$479K
58558		<1%	300	$479K
71275	Computed tomographic angiography, chest, with contrast material	<1%	4,591	$468K
84443	Thyroid stimulating hormone (TSH)	<1%	56,385	$467K
41899	Unlisted procedure, dentoalveolar structures	<1%	987	$420K
96415		<1%	5,238	$415K
45378	Colonoscopy, flexible; diagnostic, including collection of specimen(s)	<1%	731	$411K
J2505	Injection, pegfilgrastim, 6 mg	<1%	160	$409K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	<1%	1,971	$380K
36430		<1%	3,167	$371K
82947		<1%	198,135	$362K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	4,923	$350K
93971		<1%	5,401	$346K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	20,418	$346K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	47,502	$336K
93970		<1%	2,807	$330K
36415	Collection of venous blood by venipuncture	<1%	375,906	$327K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	2,341	$325K
76642		<1%	5,777	$321K
76825		<1%	727	$318K
70496		<1%	2,836	$307K
10061		<1%	1,053	$307K
95811		<1%	415	$299K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	23,469	$299K
83036	Hemoglobin; glycosylated (A1C)	<1%	60,793	$299K
20610		<1%	1,595	$279K
71250		<1%	5,169	$273K
J9144	Injection, daratumumab, 10 mg and hyaluronidase-fihj	<1%	83	$261K
82310		<1%	199,687	$256K
83718		<1%	38,685	$250K
77336		<1%	3,427	$241K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	37,915	$239K
J1950	Injection, leuprolide acetate (for depot suspension), per 3.75 mg	<1%	164	$237K
76641		<1%	2,671	$229K
97597		<1%	2,287	$226K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	8,961	$221K
87660		<1%	15,836	$221K
87510		<1%	15,846	$220K
87480		<1%	15,847	$220K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	20,284	$217K
72141		<1%	2,025	$215K
82607		<1%	29,073	$211K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	7,641	$209K
76770		<1%	3,128	$208K
77066	Tomosynthesis, mammo	<1%	1,866	$207K
90791	Psychiatric diagnostic evaluation	<1%	3,778	$201K
82040		<1%	81,732	$201K
82247		<1%	126,544	$197K
Q5108	Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg	<1%	104	$195K
G0399	Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation	<1%	1,714	$194K
36561		<1%	149	$193K
77300		<1%	468	$193K
27130		<1%	64	$184K
77295		<1%	283	$176K
77290		<1%	859	$176K
77080		<1%	1,801	$167K
47562		<1%	40	$163K
94010		<1%	2,118	$159K
82728		<1%	23,859	$156K
87086	Culture, bacterial; quantitative colony count, urine	<1%	50,837	$152K
P9016	Red blood cells, leukocytes reduced, each unit	<1%	2,173	$150K
86803		<1%	19,758	$146K
77063	Screening digital breast tomosynthesis, bilateral	<1%	10,488	$144K
86480		<1%	3,812	$140K
87536		<1%	3,406	$139K
Q0138	Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)	<1%	560	$137K
88342		<1%	6,787	$134K
96417		<1%	2,839	$132K
77065	Tomosynthesis, mammo	<1%	1,313	$131K
96367		<1%	3,284	$129K
0002A		<1%	3,886	$128K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	79,941	$126K
J1569	Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg	<1%	110	$123K
C8908	Magnetic resonance imaging without contrast followed by with contrast, breast; bilateral	<1%	451	$120K
G0145	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision	<1%	9,572	$120K
76536		<1%	1,625	$119K
76815	Ultrasound, pregnant uterus, real time with image documentation, limited	<1%	5,938	$118K
93975		<1%	675	$117K
83550		<1%	28,243	$116K
86235		<1%	2,358	$116K
0001A		<1%	4,064	$114K
64493		<1%	118	$113K
90677		<1%	729	$113K
72100		<1%	6,331	$111K
83013		<1%	2,402	$111K
82374		<1%	198,856	$110K
95816		<1%	953	$110K
J2469	Injection, palonosetron hcl, 25 mcg	<1%	4,369	$108K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	5,153	$107K
36591		<1%	4,918	$107K
64483		<1%	160	$105K
96416		<1%	630	$104K
82746		<1%	15,420	$104K
96411		<1%	2,059	$102K
72158		<1%	530	$101K
95911		<1%	272	$100K
73562		<1%	8,152	$99K
73030		<1%	7,950	$98K
97162		<1%	3,508	$97K
86870		<1%	715	$95K
95912		<1%	260	$93K
83970		<1%	5,168	$90K
72110		<1%	1,758	$88K
74174		<1%	716	$88K
83540		<1%	28,825	$88K
92557		<1%	1,234	$87K
70491		<1%	542	$83K
87070		<1%	22,439	$82K
80048	Basic metabolic panel (calcium, ionized)	<1%	86,568	$77K
75574		<1%	790	$77K
10060		<1%	504	$75K
87340		<1%	15,675	$75K
J0881	Injection, darbepoetin alfa, 1 microgram (non-esrd use)	<1%	1,173	$74K
87636	Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B	<1%	686	$72K
86592		<1%	23,775	$72K
71271		<1%	794	$72K
58571		<1%	16	$71K
86360		<1%	3,582	$71K
81513		<1%	813	$70K
15830		<1%	12	$69K
73610		<1%	6,766	$69K
85027		<1%	41,831	$69K
72125	Computed tomography, cervical spine; without contrast material	<1%	10,895	$68K
80053	Comprehensive metabolic panel	<1%	38,266	$68K
80061	Lipid panel	<1%	20,334	$68K
96402		<1%	2,188	$66K
G0480	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed	<1%	4,479	$66K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	1,586	$66K
88184		<1%	565	$65K
49083		<1%	112	$62K
73502		<1%	4,917	$61K
90686		<1%	8,293	$61K
73564		<1%	1,252	$60K
84153		<1%	6,778	$59K
70486		<1%	3,249	$56K
90732		<1%	921	$56K
73721	Magnetic resonance imaging, any joint of lower extremity; without contrast material	<1%	328	$56K
83735		<1%	55,464	$55K
87186		<1%	15,060	$55K
73130		<1%	6,550	$54K
72050		<1%	763	$53K
74183		<1%	252	$53K
93017		<1%	3,202	$52K
82784		<1%	6,244	$52K
86706		<1%	11,005	$51K
73700		<1%	868	$51K
J1453	Injection, fosaprepitant, 1 mg	<1%	1,207	$49K
84425		<1%	4,349	$49K
83880		<1%	15,645	$49K
84439		<1%	10,689	$49K
73630		<1%	8,281	$48K
82570		<1%	18,738	$48K
82652		<1%	2,463	$47K
90746		<1%	956	$46K
92587		<1%	186	$45K
73110		<1%	3,970	$44K
85610		<1%	54,991	$43K
G0330	Facility services for dental rehabilitation procedure(s) performed on a patient who requires monitored anesthesia (e.g., general, intravenous sedation (monitored anesthesia care) and use of an operating room	<1%	71	$43K
72156		<1%	201	$42K
86618		<1%	3,332	$42K
86140		<1%	19,267	$41K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	<1%	916	$41K
84207		<1%	3,480	$40K
82043		<1%	12,273	$39K
86334		<1%	4,985	$39K
73590		<1%	3,623	$39K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	1,297	$39K
83655		<1%	4,187	$39K
87522	Neg quan hep c or qual rna	<1%	1,700	$37K
80074		<1%	1,518	$37K
83883		<1%	4,840	$37K
82465		<1%	38,877	$37K
90670		<1%	1,803	$36K
88112		<1%	2,554	$35K
84403		<1%	2,578	$35K
86038		<1%	5,330	$35K
73560		<1%	4,233	$34K
84134		<1%	6,933	$34K
G0257	Unscheduled or emergency dialysis treatment for an esrd patient in a hospital outpatient department that is not certified as an esrd facility	<1%	473	$34K
72131		<1%	746	$34K
86160		<1%	2,717	$34K
86704		<1%	5,749	$33K
72070		<1%	1,373	$32K
J9395	Injection, fulvestrant, 25 mg	<1%	133	$32K
87633	Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets	<1%	138	$32K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	<1%	21	$31K
86920		<1%	4,027	$31K
74018		<1%	4,150	$31K
73551		<1%	2,334	$30K
G0379	Direct admission of patient for hospital observation care	<1%	34	$30K
74241		<1%	248	$30K
J0185	Injection, aprepitant, 1 mg	<1%	170	$30K
95909		<1%	144	$30K
87077		<1%	8,537	$29K
72040		<1%	2,502	$29K
78306		<1%	138	$28K
84702		<1%	10,826	$27K
93798		<1%	303	$27K
87147		<1%	10,813	$26K
19083		<1%	35	$26K
G0378	Hospital observation service, per hour	<1%	21,285	$26K
73080		<1%	2,511	$26K
52332		<1%	13	$26K
80164		<1%	3,910	$26K
85652		<1%	21,837	$26K
88304		<1%	2,669	$25K
C9803	Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	<1%	19,510	$25K
87088		<1%	6,602	$24K
76817	Ultrasound, pregnant uterus, real time with image documentation, transvaginal	<1%	10,874	$23K
J2997	Injection, alteplase recombinant, 1 mg	<1%	344	$23K
82140		<1%	3,398	$23K
97166		<1%	569	$23K
96401		<1%	1,113	$22K
84146		<1%	2,206	$22K
84165		<1%	5,751	$22K
81001		<1%	33,055	$22K
Q5118	Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg	<1%	33	$20K
76700	Ultrasound, abdominal, real time with image documentation; complete	<1%	242	$20K
84630		<1%	4,055	$20K
73060		<1%	1,844	$20K
86787		<1%	2,145	$20K
74220		<1%	206	$20K
84590		<1%	3,526	$19K
70498		<1%	3,161	$19K
72170		<1%	3,441	$19K
84446		<1%	2,583	$18K
86762		<1%	5,692	$18K
90651		<1%	1,021	$18K
96523		<1%	877	$17K
87625		<1%	704	$17K
83001		<1%	1,567	$17K
J9217	Leuprolide acetate (for depot suspension), 7.5 mg	<1%	88	$17K
90734		<1%	876	$17K
0031A		<1%	867	$17K
88173		<1%	1,250	$17K
36593		<1%	95	$16K
80202		<1%	1,398	$16K
86200		<1%	2,333	$16K
85730		<1%	22,427	$15K
86147		<1%	463	$15K
73140		<1%	1,490	$15K
73090		<1%	2,076	$15K
95910		<1%	62	$15K
90471	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine	<1%	18,377	$15K
95913		<1%	38	$15K
77062		<1%	1,182	$15K
84252		<1%	1,892	$13K
87081		<1%	4,576	$13K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	1,290	$13K
87493		<1%	618	$13K
0004A		<1%	397	$13K
82180		<1%	2,831	$13K
86431		<1%	4,286	$12K
83516		<1%	1,160	$12K
92551		<1%	1,979	$11K
83690		<1%	54,706	$11K
83021		<1%	2,786	$11K
43235		<1%	41	$11K
84255		<1%	694	$11K
80076		<1%	7,429	$10K
82378		<1%	3,166	$10K
82105		<1%	1,302	$10K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	44	$10K
82950		<1%	2,510	$10K
83002		<1%	905	$10K
74019		<1%	2,121	$10K
84156		<1%	6,752	$10K
82565		<1%	206,188	$10K
86765		<1%	1,281	$9K
80177		<1%	1,401	$9K
20680		<1%	12	$9K
86003		<1%	164	$9K
86735		<1%	1,154	$9K
0012A		<1%	679	$9K
87205		<1%	7,460	$9K
76000		<1%	411	$8K
84480		<1%	960	$8K
83020		<1%	2,788	$8K
86703		<1%	1,330	$8K
86696		<1%	614	$8K
81003		<1%	21,316	$8K
72190		<1%	101	$8K
87529		<1%	230	$7K
84597		<1%	1,373	$7K
84481		<1%	841	$7K
86255		<1%	937	$7K
88307		<1%	2,225	$7K
31629		<1%	15	$7K
20605		<1%	33	$7K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	11,860	$7K
82248		<1%	64,887	$7K
95250		<1%	87	$6K
87040		<1%	8,719	$6K
86376		<1%	786	$6K
85045		<1%	4,098	$6K
0064A		<1%	181	$6K
93880		<1%	122	$6K
87150		<1%	420	$6K
93270		<1%	406	$6K
74240		<1%	56	$6K
86695		<1%	614	$5K
84478		<1%	38,861	$5K
77280		<1%	96	$5K
74178		<1%	25	$5K
86300		<1%	2,028	$5K
80185		<1%	816	$5K
86304		<1%	863	$5K
86708		<1%	853	$5K
72197		<1%	14	$5K
83615		<1%	58,412	$5K
86812		<1%	277	$5K
82525		<1%	838	$5K
86769		<1%	124	$5K
85379		<1%	8,083	$5K
82670		<1%	274	$4K
J1610	Injection, glucagon hydrochloride, per 1 mg	<1%	43	$4K
31624		<1%	55	$4K
87184		<1%	1,575	$4K
86880		<1%	1,553	$4K
82550		<1%	13,546	$4K
83010		<1%	1,188	$4K
0011A		<1%	669	$4K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	<1%	288	$4K
36589		<1%	15	$4K
82164		<1%	540	$4K
86800		<1%	448	$4K
86146		<1%	133	$4K
77470		<1%	16	$4K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	112	$4K
86225		<1%	507	$4K
82150		<1%	41,683	$4K
84550		<1%	9,248	$4K
77307		<1%	17	$4K
90832	Psychotherapy session, about 30 minutes	<1%	93	$3K
G0123	Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision	<1%	368	$3K
88360		<1%	599	$3K
84703		<1%	5,736	$3K
84145		<1%	8,296	$3K
85018		<1%	4,058	$3K
85014		<1%	5,177	$3K
83525		<1%	411	$3K
86364		<1%	237	$3K
87486		<1%	138	$3K
87581		<1%	138	$3K
73521		<1%	87	$3K
93308		<1%	16	$3K
71100		<1%	1,010	$3K
87046		<1%	771	$3K
87324		<1%	581	$3K
84436		<1%	740	$3K
87045		<1%	768	$2K
0054A		<1%	102	$2K
36600		<1%	448	$2K
95249		<1%	56	$2K
84100		<1%	13,974	$2K
84466		<1%	358	$2K
86694		<1%	214	$2K
87449		<1%	489	$2K
84132		<1%	201,246	$2K
84484		<1%	45,035	$2K
G0297	Low dose ct scan (ldct) for lung cancer screening	<1%	28	$2K
86850		<1%	34,217	$2K
73221		<1%	12	$2K
12001		<1%	1,557	$2K
73552		<1%	157	$2K
82330		<1%	1,308	$2K
82951		<1%	167	$2K
21310		<1%	14	$2K
84450		<1%	129,608	$2K
31623		<1%	20	$2K
90656		<1%	130	$2K
20552		<1%	13	$2K
81025		<1%	28,669	$2K
87075		<1%	1,839	$1K
93923		<1%	14	$1K
80178		<1%	521	$1K
82962		<1%	73,880	$1K
73600		<1%	141	$1K
86617		<1%	101	$1K
92950		<1%	13	$1K
85613		<1%	295	$1K
84075		<1%	128,376	$1K
86901		<1%	34,374	$1K
82533		<1%	152	$1K
86141		<1%	197	$1K
81050		<1%	515	$1K
74230		<1%	12	$1K
86780		<1%	114	$1K
87517		<1%	35	$981.84
73000		<1%	32	$942.03
83605		<1%	19,483	$915.55
82435		<1%	199,037	$913.81
83721		<1%	190	$896.43
92611		<1%	12	$848.64
84460		<1%	129,574	$842.79
87255		<1%	51	$842.00
94727		<1%	4,953	$821.53
82803		<1%	5,581	$819.69
83993		<1%	65	$807.42
G0103	Prostate cancer screening; prostate specific antigen test (psa)	<1%	151	$799.85
86301		<1%	210	$797.31
97116		<1%	45	$789.48
73200		<1%	13	$788.66
31628		<1%	23	$742.50
87269		<1%	131	$740.88
87272		<1%	131	$730.42
84270		<1%	56	$730.33
80162		<1%	163	$717.85
93225		<1%	13	$713.02
87503		<1%	514	$710.26
89050		<1%	1,448	$706.75
12011		<1%	572	$681.11
77061		<1%	51	$672.40
76813		<1%	5,922	$611.87
97161		<1%	25	$605.46
84520		<1%	201,762	$557.61
82785		<1%	53	$543.90
84155		<1%	79,273	$526.14
87338		<1%	56	$524.47
86039		<1%	93	$521.02
88300		<1%	257	$518.09
72020		<1%	142	$484.90
82952		<1%	139	$474.98
92567		<1%	1,521	$465.91
83921		<1%	59	$455.00
86705		<1%	62	$450.00
86611		<1%	20	$437.40
J2310	Injection, naloxone hydrochloride, per 1 mg	<1%	266	$413.90
90715		<1%	8,300	$413.56
86308		<1%	188	$405.08
73620		<1%	59	$394.04
12002		<1%	713	$337.58
87427		<1%	35	$329.03
G2066	Interrogation device evaluation(s), (remote) up to 30 days; implantable cardiovascular physiologic monitor system, implantable loop recorder system, or subcutaneous cardiac rhythm monitor system, remote data acquisition(s), receipt of transmissions and technician review, technical support and distribution of results	<1%	26	$326.60
96376		<1%	14,847	$312.91
86665		<1%	19	$311.76
82553		<1%	6,314	$307.45
87209		<1%	32	$305.50
Q0114	Fern test	<1%	43	$273.20
90621		<1%	13	$265.74
80156		<1%	82	$256.87
82077		<1%	12,137	$248.39
93041		<1%	17,687	$247.84
76827		<1%	738	$244.28
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	<1%	2,770	$243.40
86258		<1%	12	$242.44
82085		<1%	46	$231.75
86335		<1%	16	$229.26
84295		<1%	200,164	$223.17
87177		<1%	32	$222.45
86682		<1%	17	$211.14
86593		<1%	75	$189.75
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	41,183	$181.57
51701		<1%	1,613	$173.00
89060		<1%	99	$171.99
84402		<1%	17	$170.24
84300		<1%	222	$163.63
82731		<1%	34	$157.64
82375		<1%	524	$153.01
87420		<1%	13	$148.85
80051		<1%	35	$147.40
96368		<1%	1,004	$144.35
82009		<1%	2,899	$139.59
81002		<1%	14,080	$136.17
36592		<1%	177	$135.02
87481		<1%	148	$134.04
86664		<1%	19	$131.49
83930		<1%	353	$126.20
83520		<1%	20	$123.60
83090		<1%	28	$118.48
86663		<1%	19	$112.77
84154		<1%	13	$105.36
87102		<1%	22	$104.26
90460	Immunization administration through 18 years of age via any route, first or only component	<1%	101	$100.35
85660		<1%	63	$84.49
76870		<1%	536	$79.99
70360		<1%	44	$69.15
73660		<1%	15	$69.15
87511		<1%	148	$67.02
82800		<1%	1,523	$64.90
88313		<1%	2,896	$64.65
C1760	Closure device, vascular (implantable/insertable)	<1%	757	$62.25
51702		<1%	342	$58.97
87207		<1%	30	$55.02
82977		<1%	37	$54.45
82960		<1%	14	$53.55
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	29,976	$50.34
87400		<1%	959	$49.07
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	23,426	$46.61
81015		<1%	2,156	$43.16
87653		<1%	51	$33.51
J1650	Injection, enoxaparin sodium, 10 mg	<1%	8,542	$29.61
86777		<1%	14	$27.50
J0571	Buprenorphine, oral, 1 mg	<1%	70	$25.81
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,641	$25.38
99157		<1%	589	$20.75
99156		<1%	589	$20.75
J1815	Injection, insulin, per 5 units	<1%	8,492	$19.41
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	39,032	$18.17
J1836	Injection, metronidazole, 10 mg	<1%	569	$16.00
J2270	Injection, morphine sulfate, up to 10 mg	<1%	9,794	$15.33
82945		<1%	31	$15.00
J0736	Injection, clindamycin phosphate, 300 mg	<1%	94	$13.62
J0665	Injection, bupivicaine, not otherwise specified, 0.5 mg	<1%	2,064	$13.58
J3490	Unclassified drugs	<1%	132,041	$12.27
J1644	Injection, heparin sodium, per 1000 units	<1%	15,329	$12.14
J1170	Injection, hydromorphone, up to 4 mg	<1%	27,439	$11.85
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	45,863	$10.45
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	10,048	$10.36
C1729	Catheter, drainage	<1%	881	$9.55
82272		<1%	2,171	$9.45
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	10,182	$7.96
C9113	Injection, pantoprazole sodium, per vial	<1%	3,501	$7.85
85362		<1%	15	$6.58
83935		<1%	12	$6.51
90472	Immunization administration, each additional vaccine (list separately)	<1%	282	$6.09
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	<1%	9,652	$4.84
G0279	Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066)	<1%	37	$4.21
J3370	Injection, vancomycin hcl, 500 mg	<1%	4,216	$3.38
C1894	Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser	<1%	6,095	$2.45
J7120	Ringers lactate infusion, up to 1000 cc	<1%	569	$2.42
G0008	Administration of influenza virus vaccine	<1%	3,565	$2.04
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	9,828	$1.91
C1769	Guide wire	<1%	7,241	$1.41
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	21,788	$1.40
J1920	Injection, labetalol hydrochloride, 5 mg	<1%	207	$1.24
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	6,194	$1.01
J0690	Injection, cefazolin sodium, 500 mg	<1%	14,692	$1.00
J3480	Injection, potassium chloride, per 2 meq	<1%	2,741	$1.00
J1171	Injection, hydromorphone, 0.1 mg	<1%	534	$0.45
J2060	Injection, lorazepam, 2 mg	<1%	8,281	$0.39
G8979	Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting	<1%	101	$0.36
G8978	Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals	<1%	98	$0.34
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	4,509	$0.10
C1758	Catheter, ureteral	0%	847	$0.00
J0640	Injection, leucovorin calcium, per 50 mg	0%	385	$0.00
93325		0%	1,509	$0.00
J2710	Injection, neostigmine methylsulfate, up to 0.5 mg	0%	2,548	$0.00
J2919	Injection, methylprednisolone sodium succinate, 5 mg	0%	811	$0.00
J1580	Injection, garamycin, gentamicin, up to 80 mg	0%	462	$0.00
A9552	Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries	0%	1,946	$0.00
Q9957	Injection, perflutren lipid microspheres, per ml	0%	2,809	$0.00
91300		0%	7,762	$0.00
J1756	Injection, iron sucrose, 1 mg	0%	9,538	$0.00
90681		0%	271	$0.00
C1887	Catheter, guiding (may include infusion/perfusion capability)	0%	1,574	$0.00
Q0163	Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen	0%	5,405	$0.00
76376		0%	455	$0.00
J3475	Injection, magnesium sulfate, per 500 mg	0%	7,042	$0.00
90714		0%	301	$0.00
J0171	Injection, adrenalin, epinephrine, 0.1 mg	0%	970	$0.00
76937		0%	878	$0.00
C1713	Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable)	0%	2,496	$0.00
99152		0%	3,309	$0.00
80143		0%	651	$0.00
A9575	Injection, gadoterate meglumine, 0.1 ml	0%	4,497	$0.00
J3301	Injection, triamcinolone acetonide, not otherwise specified, 10 mg	0%	1,098	$0.00
J9190	Injection, fluorouracil, 500 mg	0%	1,351	$0.00
94729		0%	5,533	$0.00
J1953	Injection, levetiracetam, 10 mg	0%	1,147	$0.00
J1240	Injection, dimenhydrinate, up to 50 mg	0%	2,777	$0.00
87210		0%	220	$0.00
90633		0%	456	$0.00
80179		0%	555	$0.00
Q9966	Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml	0%	2,476	$0.00
90713		0%	272	$0.00
J0702	Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg	0%	192	$0.00
90648		0%	669	$0.00
J0692	Injection, cefepime hydrochloride, 500 mg	0%	611	$0.00
C1776	Joint device (implantable)	0%	1,473	$0.00
S0077	Injection, clindamycin phosphate, 300 mg	0%	78	$0.00
J3489	Injection, zoledronic acid, 1 mg	0%	177	$0.00
J9263	Injection, oxaliplatin, 0.5 mg	0%	329	$0.00
93356		0%	523	$0.00
90671		0%	70	$0.00
95251		0%	37	$0.00
29125		0%	137	$0.00
J2550	Injection, promethazine hcl, up to 50 mg	0%	142	$0.00
90710		0%	215	$0.00
J1596	Injection, glycopyrrolate, 0.1 mg	0%	329	$0.00
90700		0%	13	$0.00
76942		0%	74	$0.00
C1788	Port, indwelling (implantable)	0%	134	$0.00
J7040	Infusion, normal saline solution, sterile (500 ml = 1 unit)	0%	90	$0.00
90685		0%	272	$0.00
J0780	Injection, prochlorperazine, up to 10 mg	0%	333	$0.00
J0744	Injection, ciprofloxacin for intravenous infusion, 200 mg	0%	110	$0.00
J7030	Infusion, normal saline solution , 1000 cc	0%	627	$0.00
M1145	Most favored nation (mfn) model drug add-on amount, per dose, (do not bill with line items that have the jw modifier)	0%	16	$0.00
J2916	Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg	0%	24	$0.00
97803		0%	65	$0.00
C1874	Stent, coated/covered, with delivery system	0%	63	$0.00
77012		0%	40	$0.00
82805		0%	56	$0.00
J2272	Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg	0%	32	$0.00
A9541	Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries	0%	13	$0.00
88312		0%	13	$0.00
99153	Mod sedat endo service >5yrs	0%	3,224	$0.00
J2785	Injection, regadenoson, 0.1 mg	0%	2,070	$0.00
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	0%	6,589	$0.00
A4648	Tissue marker, implantable, any type, each	0%	380	$0.00
95885		0%	44	$0.00
88341		0%	2,933	$0.00
J9267	Injection, paclitaxel, 1 mg	0%	639	$0.00
J0330	Injection, succinylcholine chloride, up to 20 mg	0%	423	$0.00
J1630	Injection, haloperidol, up to 5 mg	0%	3,967	$0.00
J1940	Injection, furosemide, up to 20 mg	0%	2,770	$0.00
J2360	Injection, orphenadrine citrate, up to 60 mg	0%	5,625	$0.00
J8540	Dexamethasone, oral, 0.25 mg	0%	9,980	$0.00
J2920	Injection, methylprednisolone sodium succinate, up to 40 mg	0%	1,882	$0.00
J0360	Injection, hydralazine hcl, up to 20 mg	0%	587	$0.00
88311		0%	546	$0.00
77001		0%	661	$0.00
G0009	Administration of pneumococcal vaccine	0%	1,353	$0.00
76820		0%	2,396	$0.00
C1781	Mesh (implantable)	0%	230	$0.00
J2371	Injection, phenylephrine hydrochloride, 20 micrograms	0%	482	$0.00
J2470	Injection, pantoprazole sodium, 40 mg	0%	278	$0.00
Q3014	Telehealth originating site facility fee	0%	920	$0.00
95886		0%	2,439	$0.00
J1720	Injection, hydrocortisone sodium succinate, up to 100 mg	0%	237	$0.00
J2704	Injection, propofol, 10 mg	0%	37,985	$0.00
J3411	Injection, thiamine hcl, 100 mg	0%	263	$0.00
J1030	Injection, methylprednisolone acetate, 40 mg	0%	1,391	$0.00
G0010	Administration of hepatitis b vaccine	0%	244	$0.00
J1040	Injection, methylprednisolone acetate, 80 mg	0%	2,496	$0.00
94660		0%	528	$0.00
88185		0%	568	$0.00
J9045	Injection, carboplatin, 50 mg	0%	566	$0.00
C1725	Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability)	0%	884	$0.00
J1790	Injection, droperidol, up to 5 mg	0%	1,716	$0.00
J0280	Injection, aminophyllin, up to 250 mg	0%	634	$0.00
Q9963	High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml	0%	259	$0.00
J2370	Injection, phenylephrine hcl, up to 1 ml	0%	723	$0.00
91305		0%	198	$0.00
J0456	Injection, azithromycin, 500 mg	0%	214	$0.00
94761		0%	200	$0.00
91301		0%	875	$0.00
J2175	Injection, meperidine hydrochloride, per 100 mg	0%	445	$0.00
90619		0%	96	$0.00
J1010	Injection, methylprednisolone acetate, 1 mg	0%	218	$0.00
J0131	Injection, acetaminophen, not otherwise specified,10 mg	0%	1,508	$0.00
G0108	Diabetes outpatient self-management training services, individual, per 30 minutes	0%	229	$0.00
0399T		0%	119	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	33	$0.00
C2617	Stent, non-coronary, temporary, without delivery system	0%	64	$0.00
91303		0%	864	$0.00
A9503	Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries	0%	274	$0.00
51798		0%	139	$0.00
90696		0%	67	$0.00
91306		0%	159	$0.00
12013		0%	28	$0.00
C2627	Catheter, suprapubic/cystoscopic	0%	205	$0.00
J7050	Infusion, normal saline solution, 250 cc	0%	135	$0.00
64494		0%	72	$0.00
G0475	Hiv antigen/antibody, combination assay, screening	0%	175	$0.00
G0472	Hepatitis c antibody screening, for individual at high risk and other covered indication(s)	0%	95	$0.00
J2003	Injection, lidocaine hydrochloride, 1 mg	0%	316	$0.00
J1805	Injection, esmolol hydrochloride, 10 mg	0%	17	$0.00
86905		0%	19	$0.00
C1726	Catheter, balloon dilatation, non-vascular	0%	28	$0.00
77417		0%	29	$0.00
G0499	Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result	0%	14	$0.00
J3360	Injection, diazepam, up to 5 mg	0%	67	$0.00
76377		0%	27	$0.00
11045		0%	18	$0.00
96377		0%	17	$0.00
95012		0%	12	$0.00
99292		0%	13	$0.00
97802		0%	21	$0.00
31654		0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialHARRIS, JAMES (REGIONAL DIRECTOR OF REIMBURSEMENT)

Parent organizationTRINITY HEALTH OF NEW ENGLAND CORPORATION INC

Same official

Other billing entities under HARRIS, JAMES

Full network →

Provider	Location	Paid
Saint Mary's Hospital, INC.	Waterbury, CT	$163.27M
The Mercy Hospital INC	Springfield, MA	$98.92M
Trinity Health of New England Provider Network Organization INC	Hartford, CT	$41.97M
Riverbend Medical Group, INC.	Springfield, MA	$38.70M
System Coordinated Services, INC	Springfield, MA	$18.54M
Brightside INC	Springfield, MA	$11.41M
The Mercy Hospital INC	Holyoke, MA	$10.93M
Mercy Inpatient Medical Associates INC.	Springfield, MA	$6.96M
State of New York Comptrollers Office	Buffalo, NY	$6.05M
Saint Francis Care Medical Group, PC	Hartford, CT	$2.00M
Saint Francis Hospital and Medical Center	Hartford, CT	$1.42M
Pioneer Valley Cardiology Associates, INC	Springfield, MA	$1.31M
Mercy Medical Group, INC.	Springfield, MA	$1.08M
Saint Francis Hospital and Medical Center	Hartford, CT	$382K
Prater Volunteer Rescue Squad INC	Grundy, VA	$331K
Diabetes and Lifestyle Management, LLC	Derry, NH	$273K
Mercy Specialist Physicians INC	Springfield, MA	$101K
Health Access, INC.	Clarksburg, WV	$85K
Gibson County Podiatry LLC	Milan, TN	$83K
Saint Francis Hospital and Medical Center	Hartford, CT	$45K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.